WHO ICTRP trial

Study of Clenil® Modulite® at different times of the day in Asthma

EUCTR2019-004309-28-GB · EU Clinical Trials Register · Authorised

Key facts

Trial ID EUCTR2019-004309-28-GB
Public title Study of Clenil® Modulite® at different times of the day in Asthma
Scientific title Application of Chronotherapy to Asthma: Towards the Personalisation of Asthma Management. A randomised, mechanistic study of 400mcg Clenil® Modulite® (Beclometasone dipropionate) in the morning versus in the afternoon versus 200mcg twice a day, in Subjects with Atopic Mild to Moderate Asthma - Study…
Primary sponsor The Medicines Evaluation Unit (MEU) Ltd. (Investigator led study)
Registry EU Clinical Trials Register
Recruitment status Authorised
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes
Countries United Kingdom
Conditions Mild to moderate atopic asthma MedDRA version: 21.1 Level: LLT Classification code 10001705 Term: Allergic asthma System Organ Class: 100000004855 ;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
Interventions Trade Name: Clenil® Modulite® 200 micrograms per actuation pressurised inhalation solution Product Name: Clenil® Modulite® 200 micrograms per actuation pressurised inhalation solution Pharmaceutical Form: Pressurised inhalation, solution…
Registration date Dec 16, 2019
Target size 25
Secondary IDs MEU19/383;MEU 19/383
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations